Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed granted inducement equity awards to 128 new employees under its 2025 Inducement Plan, structured to comply with Nasdaq Listing Rule 5635(c)(4). The August 31, 2026 grants comprised 115,320 restricted stock units and options to purchase 5,560 shares at an exercise price of $121.82, set at the grant-date closing price; both award types vest over four years.
Key figures
- Vesting
- four-year vesting for both RSUs and options; options have a 10-year term
- Grant date
- 2026-08-31
- Rsus granted
- 115320
- New employees
- 128
- Option shares
- 5560
- Option exercise price
- 121.82
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.